“World Class defined and enabled” is the strapline used by the leading global business transformation consultancy, The Hackett Group.
Christopher Davenport, a Director at the The Hackett Group, recently co-hosted a business engagement event on Digital Strategy and Business Transformation with Dr John Oliver from the Advances in Media Management research group. The event was held in London and formed part of a British Academy/Leverhulme Trust funded project into the successful digital transformations of media firms.
The event was attended by senior business executives from the likes of Ofcom, The Financial Times, Astrazeneca and Bell Pottinger who commented that is was an “excellent event” that provided not only different perspectives on digital transformation, but new ideas and tools that will help them to be more effective in managing business transformation within their firms.
Dr Oliver commented that “Chris Davenport and The Hackett Group have been immensely helpful and supportive in developing methodological ideas and ultimately the dissemination of the research findings”. The feedback from the event participants was highly positive and that it provided a useful platform to discuss and share their experiences of managing the complexity of the digital environment.
The Impact of Digital Strategy and Business Transformation
Shaping Media Policy and Regulation










Join the 17th Annual Postgraduate Research Conference – Wednesday 3 December 2025
BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
BU PhD student attending HIV conference on scholarship
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease